Delivery Order SPE2DB22D3501-SPE2DB25FWR59
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,999.35 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,473.76 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract is unclassified as a set-aside procurement and will...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $50,511.39 for NURTEC ODT 75 mg tablets (8-count packaging) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is listed as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $49,744.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location in...
- The Defense Logistics Agency awarded a $23,180.90 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) under a firm fixed-price contract. The delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $24,953.82 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a $6,675.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-competitive, non-set-aside award represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) valued at $9,331.74. This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, represents a non-competitive set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for acute migraine treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $12,539.71 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packaging). This firm fixed price, non-set-aside contract was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's extensive...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWR59Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,843.25 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract awarded under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. NURTEC ODT is a medication used in the treatment of migraine headaches and represents part of the company's broader portfolio of neurological and specialty pharmaceutical products supplied to federal healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. As a child contract, this order exemplifies the company's role as a critical vendor within the federal medical supply chain, delivering specialized medications to support military personnel and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 7/31/25 |